Key result
Knockout of SIRT3 in mice enhanced Ang-II-induced cardiac fibrosis, capillary rarefaction, and hypertrophy via pericyte-myofibroblast transition and the ROS-TGF-β1 pathway.
Why the study?
Hypertension drives cardiac fibrosis and diastolic dysfunction, and SIRT3 knockout previously caused diastolic dysfunction in mice, prompting investigation into the role of SIRT3 in Ang-II-induced cardiac fibrosis and pericyte-myofibroblast transition.
Does SIRT3 knockout exacerbate Ang-II-induced cardiac fibrosis and pericyte transition in mice?
Does SIRT3 knockout exacerbate Ang-II-induced cardiac fibrosis and pericyte transition in mice?
SIRT3 plays a protective role against hypertension-induced cardiac fibrosis and diastolic dysfunction by regulating pericyte-myofibroblast transition and the ROS-TGF-β1 pathway.
SIRT3 may be a therapeutic target in cardiac fibrosis; leaves open clinical translation from murine models.
Hypertension is the key factor for the development of cardiac fibrosis and diastolic dysfunction. Our previous study showed that knockout of sirtuin 3 (SIRT3) resulted in diastolic dysfunction in mice. In the present study, we explored the role of SIRT3 in angiotensin II (Ang‐II)–induced cardiac fibrosis and pericyte‐myofibroblast transition. NG2 tracing reporter NG2‐DsRed mouse was crossed with wild‐type (WT) mice and SIRT3KO mice. Cardiac function, cardiac fibrosis and reactive oxygen species (ROS) were measured. Mice infused with Ang‐II for 28 days showed a significant reduction of SIRT3 expression in the mouse hearts. Knockout of SIRT3 sensitized Ang‐II‐induced elevation of isovolumic relaxation time (IVRT) and reduction of ejection fraction (EF) and fractional shortening (FS). Ang‐II‐induced cardiac fibrosis, capillary rarefaction and hypertrophy were further enhanced by knockout of SIRT3. NG2 pericyte tracing reporter mice infused with Ang‐II had a significantly increased number of NG2‐DsRed pericyte in the heart. Knockout of SIRT3 further enhanced Ang‐II‐induced increase of pericytes. To examine pericyte‐myofibroblast/fibroblast transition, DsRed pericytes were co‐stained with FSP‐1 and α‐SMA. Ang‐II infusion led to a significant increase in numbers of DsRed + /FSP‐1 + and DsRed + /α‐SMA + cells, while SIRT3KO further developed pericyte‐myofibroblast/fibroblast transition. In addition, knockout of SIRT3 promoted Ang‐II‐induced NADPH oxidase‐derived ROS formation together with increased expression of transforming growth factor beta 1 (TGF‐β1). We concluded that Ang‐II induced cardiac fibrosis partly by the mechanisms involving SIRT3‐mediated pericyte‐myofibroblast/fibroblast transition and ROS‐TGF‐β1 pathway.
No takes yet. Share an insight, caveat, or question.
Su et al. (2020) studied Hypertension-induced cardiac fibrosis. SIRT3 knockout vs. Wild-type mice was evaluated on Cardiac fibrosis and pericyte-myofibroblast transition. Knockout of SIRT3 in mice enhanced Ang-II-induced cardiac fibrosis, capillary rarefaction, and hypertrophy via pericyte-myofibroblast transition and the ROS-TGF-β1 pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: